Back to
Pacer Advisors, Inc.
GSK1
16 quarters
Position history for
Pacer Advisors, Inc.'s holdings in GLAXOSMITHKLINE PLC-SPON ADR
As of its Q2 2022 13F, Pacer Advisors held 290,909 shares of GSK1 (Glaxosmithkline), worth $12.7M. Pacer Advisors' 13F filings listed GSK1 from Q2 2020 to Q2 2022, 9 quarterly filings. GSK1 was 0.1% of Pacer Advisors' reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$4M
Total Shares Change
-104,099
Quarter-by-Quarter History
Other major holders of GSK1: Dodge & Cox